Storia in 2 fonti

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation

Raccontata da

medpagetoday.com

healio.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo4 g fa

GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication

Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation

originale

healio.com2 g fa

SGLT2 inhibitors linked to greater risk for major diabetic foot complications vs. GLP-1s

CHICAGO — Major diabetic foot complications were more common in patients with type 2 diabetes treated with SGLT2 inhibitors than those treated with GLP-1 receptor agonists, researchers reported at ENDO 2026.However,…

Leggi questa versione → originale

Timeline cronologica

sabato 13 giugno 2026·medpagetoday.com
GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication
Real-world data found patients on GLP-1s had lower odds of osteomyelitis, ulcers, and amputation
lunedì 15 giugno 2026·healio.com
SGLT2 inhibitors linked to greater risk for major diabetic foot complications vs. GLP-1s
CHICAGO — Major diabetic foot complications were more common in patients with type 2 diabetes treated with SGLT2 inhibitors than those treated with GLP-1 receptor agonists,…